MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC

被引:6
|
作者
Fang, Wenfeng [1 ]
Gan, Jiadi [1 ]
Hong, Shaodong [1 ]
Lu, Feng [2 ]
Zhang, Li [1 ]
机构
[1] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
[2] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China
基金
国家重点研发计划;
关键词
CELL LUNG-CANCER; FUSION;
D O I
10.1016/j.jtho.2019.02.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E148 / E151
页数:5
相关论文
共 50 条
  • [21] Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion
    Tsou, Terrence C.
    Gowen, Kyle
    Ali, Siraj M.
    Miller, Vincent A.
    Schrock, Alexa B.
    Lovly, Christine M.
    Reckamp, Karen L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (02) : E29 - E30
  • [22] Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC
    Al-Samkari, Hanny
    Leiva, Orly
    Dagogo-Jack, Ibiayi
    Shaw, Alice
    Lennerz, Jochen
    Iafrate, Anthony J.
    Bendapudi, Pavan K.
    Connors, Jean M.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (09) : 1497 - 1506
  • [23] A NOVEL ALK REARRANGEMENT A2M-ALK IN A NEONATE WITH FETAL LUNG INTERSTITIAL TUMOR
    Onoda, T.
    Kanno, M.
    Sato, H.
    Takahashi, N.
    Izumino, H.
    Ohta, H.
    Emura, T.
    Katoh, H.
    Ohizumi, H.
    Ohtake, H.
    Asao, H.
    Dehner, L. P.
    Hill, A. D.
    Hayasaka, K.
    Mitsui, T.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S370 - S370
  • [24] SHP2 inhibition restores sensitivity to ALK inhibitors in resistant ALK-rearranged NSCLC
    Dardaei, Leila
    Wang, Hui Qin
    Singh, Manrose
    Fordjour, Paul
    Yoda, Satoshi
    Kerr, Grainne
    Liang, Jinsheng
    Cao, Yichen
    Chen, Yan
    Gainor, Justin
    Friboulet, Luc
    Dagogo-Jack, Ibiayi
    Myers, David
    Labrot, Emma
    Ruddy, David
    Parks, Melissa
    Lee, Dana
    DiCecca, Richard
    Moody, Susan
    Hao, Huaixiang
    Mohseni, Morvarid
    LaMarche, Matthew
    Williams, Juliet
    Hoffmaster, Keith
    Caponigro, Giordano
    Shaw, Alice
    Hata, Aaron
    Benes, Cyril
    Li, Fang
    Engelman, Jeffrey
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [25] ALK Inhibitor and Chemotherapy Combinations in Models of ALK-Translocated NSCLC
    Luukkainen, Milla E. k
    Koivunen, Jussi P.
    ANTICANCER RESEARCH, 2024, 44 (07) : 2805 - 2813
  • [26] ALK plus NSCLC ALK Inhibitors symbolize Progress in Cancer Medicine
    Kohl, Angelika
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (7-8) : 435 - 435
  • [27] Description of ALK plus NSCLC patient characteristics and ALK testing patterns
    Wakelee, Heather A.
    Sasane, Medha
    Zhang, Jie
    Macalalad, Alexander R.
    Galebach, Philip J.
    Jarvis, John
    Kageletry, Andrew James
    Huang, Qing
    Culver, Kenneth W.
    Wu, Eric Qiong
    Guerin, Annie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Description of ALK plus NSCLC Patient Characteristics and ALK Testing Patterns
    Wakelee, H. A.
    Sasane, M.
    Zhang, J.
    Macalalad, A. R.
    Galebach, P.
    Jarvis, J.
    Kageleiry, A.
    Huang, Q.
    Culver, K.
    Wu, E. Q.
    Guerin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S60 - S61
  • [29] Spitzoid melanoma with histopathological features of ALK gene rearrangement exhibiting ALK copy number gain: a novel mechanism of ALK activation in spitzoid neoplasia
    Farah, M.
    Nagarajan, P.
    Curry, J. L.
    Tang, Z.
    Kim, T-B
    Aung, P. P.
    Torres-Cabala, C. A.
    Eterovic, A. K.
    Wargo, J. A.
    Prieto, V. G.
    Tetzlaff, M. T.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (02) : 404 - 408
  • [30] Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant
    To, Ka-Fai
    Tong, Joanna H. M.
    Yeung, King S. F.
    Lung, Raymond W. M.
    Law, Peggy P. Y.
    Chau, Shuk Ling
    Kang, Wei
    Tong, Carol Y. K.
    Chow, Chit
    Chan, Anthony W. H.
    Leung, Linda K. S.
    Mok, Tony S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 883 - 891